Biology Reference
In-Depth Information
Downing JF, Pasula R, Wright JR, Twigg HL, Martin IWJ. 1995. Surfactant protein A pro-
motes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with
human immunode®ciency virus. Proc Natl Acad Sci USA 92: 4848±4852.
Ezekowitz RAB, Sastry K, Bailly P, Warner A. 1990. Molecular characterization of the human
macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like do-
mains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 172: 1785±1794.
Fauci AS. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384: 529±534.
Fearon DT, Locksley RM. 1996. The instructive role of innate immunity in the acquired immune
response. Science 272: 50±54.
Fels A, Cohn Z. 1986. The alveolar macrophage. J Appl Physiol 60: 353±369.
Fraser IP, Takahashi K, Koziel H, Fardin B, Harmsen A, Ezekowitz RAB. 2000. Pneumocystis
carinii enhances the production of soluble mannose receptor by macrophages. Microbes Infect 2:
1305±1310.
Gadek JE, Hunninghake GW, Zimmerman RL, Crystal RG. 1980. Regulation of the release of
alveolar macrophage-derived neutrophil chemotactic factor. Am Rev Respir Dis 121: 723±733.
Greenberg S, Silverstein SC. 1993. Phagocytosis. In: Paul WE (ed). Fundamental Immunology.
New York, Raven Press, pp 941±964.
Greene WC. 1991. The molecular biology of human immunode®ciency virus type 1 infection. N
Engl J Med 324: 308±317.
Guay LA, Sierra-Madero G, Finegan CK, Rich EA. 1997. Mediation of entry of human im-
munode®ciency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-
associated protein-A. Am J Respir Cell Mol Biol 16: 421±428.
Hawgood S, Clements J. 1990. Pulmonary surfactant and its apoproteins. J Clin Invest 86: 1±6.
Honda Y, Rogers L, Nakata K, Zhao BY, Pine R, Nakai Y, Kurosu K, Rom WN, Weiden M.
1998. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)
beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters
C/EBP expression, enhancing HIV-1 replication. J Exp Med 188: 1255±1265.
Hunninghake GW, Gradek JE, Szapiel SV, Strumpf IJ, Kawanami O, Ferrans VJ, Keogh BA,
Crystal RG. 1980. The human alveolar macrophage. In: Harris CC, Trump BF, Stoner GD
(eds). Methods in Cell Biology. New York, Academic Press, pp 95±112.
Ieong MH, Reardon CC, Levitz SM, Kornfeld H. 2000. Human immunode®ciency virus type 1
infection of alveolar macrophages impairs their innate fungicidal activity. Am J Respir Crit Care
Med 162: 966±970.
Israel-Biet D, Cadranel J, Beldjord K, Andrieu JM, Je¨rey A, Even P. 1991. Tumor necrosis factor
production in HIV-seropositive subjects. Relationship with lung opportunistic infections and
HIV expression in alveolar macrophages. J Immunol 147: 490±494.
Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, Tacahashi K. 1994. Mono-
cyte chemoattractant protein-1 in idiopathic pulmonary ®brosis and other interstitial lung dis-
eases. Hum Pathol 25: 455±463.
Je¨rey AA, Israel-Biet D, Andrieu JM, Even P, Venet A. 1991. HIV isolation from pulmonary cells
derived from bronchoalveolar lavage. Clin Exp Immunol 85: 488±492.
Kelley J. 1990. Cytokines of the lung. Am Rev Resp Dis 141: 765±788.
Koziel H, Eichbaum Q, Kruskal BA, Pinkston P, Rogers RA, Armstrong MYK, Richards FF,
Rose RM, Ezekowitz RAB. 1998a. Reduced binding and phagocytosis of Pneumocystis carinii
by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor
downregulation. J Clin Invest 102: 1332±1344.
Koziel H, Phelps DS, Fishman JA, Armstrong MYK, Richards FF, Rose RM. 1998b. Surfactant
protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macro-
phages in vitro. Am J Respir Cell Mol Biol 18: 834±843.
